Posted on June 25, 2015
Last month, we traveled to Chicago to attend the American Society of Clinical Oncology’s (ASCO) Annual Meeting. This is where the top up-and-coming cancer research from the year is presented to more than 25,000 experts, advocates, doctors, researchers and scientists from around the world. Our very own Dr. Laura Porter attended and has been keeping a close eye as studies and information have continued to be released. When it was announced that one of the most exciting experimental drugs would be accepting applicants for a new study, she immediately flagged this as something we needed to get out ASAP.
Here’s what you need to know:
One of the most exciting presentations from ASCO was the results of a clinical trial for a new colorectal cancer drug called pembrolizumab (Keytruda). This drug was hailed as a breakthrough for a subset of patients with metastatic colorectal cancer (mCRC). Pembrolizumab is a monoclonal antibody, which means it works to restore the body’s immune response to tumor cells, enabling a patient’s own body to kill the cancer. Read more
Posted on June 24, 2015
Sari Stone hasn’t even started high school and she’s already making a huge impact. After losing her grandmother Miriam to colon cancer, Sari knew she wanted to honor her legacy. So, for her bat mitzvah, she set up a philanthropic fund where people could contribute. Instead of keeping the more than $6,000 she raised, Sari decided to donate to us here at the Colon Cancer Alliance!
We got a chance to speak with Sari and learn why raising colon cancer awareness is so important to her.
Posted on June 22, 2015
Earlier this month, we celebrated National Cancer Survivors Day with our first ever Survivor Week! We counted down to the big day with a week of useful survivorship information, inspiring stories, advice and encouraging words.
Posted on June 16, 2015
We’re happy to have our new Development Intern Matt Lechance join the Colon Cancer Alliance family! Matt’s a rising senior at American University where he’s double majoring in International Studies and Business. Help us welcome this Rochester, NY native!
Posted on June 12, 2015
Did you know more than 18,000 African Americans are diagnosed with colon cancer each year? Unfortunately, this community also has higher colon cancer death rates than any other racial group. But it doesn’t have to be this way.
Screening saves lives and there’s no time like the present, so we’ve teamed up with the National Black Church Initiative (NBCI) to launch Now is the Time—our new church-based initiative that’s all about preventing colon cancer by increasing screening rates among African Americans. With Congressman Donald M. Payne, Jr. joining as Honorary Chair, we’re prepared to tackle this issue head on.